LacNAc-VC-PAB-MMAE

MedChem Express

LacNAc-VC-PAB-MMAE

999

Research Use Only

C74H116N12O23

1541.78

LacNAc-VC-PAB-MMAE is a component of an Antibody-Drug Conjugate (ADC). LacNAc-VC-PAB-MMAE is assembled onto the N-glycosylation site of Trastuzumab (HY-P9907) by WT Endo-S2[1].

O=C(CO/N=C/[C@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]2[C@@H]([C@H]3N=C(O[C@H]3O[C@@H]2CO)C)O)N[C@H](C(N[C@@H](CCCNC(N)=O)C(NC4=CC=C(COC(N(C)[C@H](C(N[C@H](C(N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(N5CCC[C@H]5[C@@H]([C@H](C(N[C@@H]([C@@H](O)C6=CC=CC=C6)C)=O)C)OC)=O)=O)C(C)C)=O)C(C)C)=O)C=C4)=O)=O)C(C)C

41115800